| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0001776 | Leukocyte homeostasis | Affects phenotype | PMID:34994547 |
| GO:0001780 | Neutrophil homeostasis | Affects phenotype | PMID:34994547 |
| GO:0002260 | Lymphocyte homeostasis | Affects phenotype | PMID:34994547 |
| GO:0003990 | Acetylcholinesterase activity | Decreases phenotype | PMID:21472459 |
| GO:0004111 | Creatine kinase activity | Decreases phenotype | PMID:21472459 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:35822628 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:35822628 |
| GO:0006308 | Dna catabolic process | Increases phenotype | PMID:35822628 |
| GO:0006520 | Amino acid metabolic process | Affects phenotype | PMID:34994547 |
| GO:0006631 | Fatty acid metabolic process | Affects phenotype | PMID:34994547 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:34265337; PMID:35822628 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:19389042; PMID:24394491 |
| GO:0007033 | Vacuole organization | Increases phenotype | PMID:33592256 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:35822628 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:34994547 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:30578594 |
| GO:0008284 | Positive regulation of cell population proliferation | Decreases phenotype | PMID:29208485 |
| GO:0008285 | Negative regulation of cell population proliferation | Affects phenotype | PMID:24216299 |
| GO:0010718 | Positive regulation of epithelial to mesenchymal transition | Increases phenotype | PMID:27481218 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:21472459; PMID:33592256 |
| GO:0016887 | Atp hydrolysis activity | Decreases phenotype | PMID:21472459 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:21472459 |
| GO:0019752 | Carboxylic acid metabolic process | Affects phenotype | PMID:34994547 |
| GO:0019858 | Cytosine metabolic process | Affects phenotype | PMID:34994547 |
| GO:0030103 | Vasopressin secretion | Decreases phenotype | PMID:17434953 |
| GO:0030199 | Collagen fibril organization | Increases phenotype | PMID:33592256 |
| GO:0030335 | Positive regulation of cell migration | Increases phenotype | PMID:27481218 |
| GO:0031323 | Regulation of cellular metabolic process | Affects phenotype | PMID:28965233 |
| GO:0031547 | Brain-derived neurotrophic factor receptor signaling pathway | Affects phenotype | PMID:24394491 |
| GO:0034116 | Positive regulation of heterotypic cell-cell adhesion | Decreases phenotype | PMID:27481218 |
| GO:0040018 | Positive regulation of multicellular organism growth | Decreases phenotype | PMID:29208485 |
| GO:0042127 | Regulation of cell population proliferation | Affects phenotype | PMID:24216299 |
| GO:0042403 | Thyroid hormone metabolic process | Affects phenotype | PMID:33592256 |
| GO:0042981 | Regulation of apoptotic process | Affects phenotype | PMID:24216299 |
| GO:0043065 | Positive regulation of apoptotic process | Affects phenotype | PMID:24216299 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:35822628 |
| GO:0045669 | Positive regulation of osteoblast differentiation | Decreases phenotype | PMID:25795401 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:34265337 |
| GO:0046323 | Glucose import | Affects phenotype | PMID:34265337 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:19389042 |
| GO:0046622 | Positive regulation of organ growth | Decreases phenotype | PMID:29208485 |
| GO:0048011 | Neurotrophin trk receptor signaling pathway | Affects phenotype | PMID:24394491 |
| GO:0050665 | Hydrogen peroxide biosynthetic process | Increases phenotype | PMID:21472459 |
| GO:0051726 | Regulation of cell cycle | Affects phenotype | PMID:24216299 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:35822628 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:35822628 |
| GO:0071475 | Cellular hyperosmotic salinity response | Increases phenotype | PMID:28579251 |
| GO:0071711 | Basement membrane organization | Decreases phenotype | PMID:33592256 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:24394491; PMID:34265337 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:35822628; PMID:35872225 |
| GO:2000845 | Positive regulation of testosterone secretion | Decreases phenotype | PMID:29208485 |
| GO:2000866 | Positive regulation of estradiol secretion | Decreases phenotype | PMID:29208485 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.